Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis
Clinical trial NCT01646073 · COMPLETED
Trial details
- NCT number
- NCT01646073
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2013-12-01
- Enrollment
- 425
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.